January 20, 2016
A study exploring why people enrolled in antiretroviral treatment programs across three African countries are "lost to follow-up" reveals obstacles to reaching the third "90" of UNAIDS recipe for success against the global HIV pandemic, and points to answers that can lie within communities where rates of HIV are high.
The study, "Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients On Antiretroviral Therapy in Eastern Africa," released last week in Clinical Infectious Diseases, was led by Elvin Geng of San Francisco General Hospital's Division of HIV/AIDS, and carried out across 14 sites in Uganda, Tanzania, and Kenya.
Looking at a population of more than 18,000 patients, and following available information on the 18 percent, or 3150 patients, who were lost to follow-up, researchers found nearly 70 percent were alive and confirmed the care status of 278.
This excerpt was cross-posted with the permission of Science Speaks. Read the full article.
|Tools for Monitoring HIV Care: HIV Clinical Quality Measures|
|This Week in HIV Research: Tenofovir Alafenamide (TAF) Single-Tablet Regimen; Retention in Care; and Better Resistance Test|
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.